Publication #7668

Reference
CEM/CMO/2022/011
Name
COVID therapeutic alert 2022 11 - Commencement of a Palivizumab Passive Immunisation Programme Against Respiratory Syncytial Virus (RSV) in At Risk Infants in England, Scotland and Wales
Categories
Scottish Government Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
DRUG THERAPY PHARMACEUTICAL SERVICES
Description
Attaches a CMO letter about the commencement of the palivizumab passive immnunisation programme for respiratory syncytial virus COVID-19 for dissemination to relevant healthcare professionals for onward transmission.

This alert updates and replaces the previous alert CEM/CMO/2022/003 issued on 28 January 2022.


Contact Name
Irene Fazakerley
Contact Address
Scottish Government<br> St Andrew’s House<br> Regent Road<br> Edinburgh EH1 3DG.
Contact Phone

Created
2022-07-04 00:00:00


Click to go back to homepage